EODData

MEMBERSHIP REGISTER LOG IN

FRA, PHGN: Pharming Group NV

06 Nov 2025
LAST:

1.383

CHANGE:
 0.23		OPEN:
1.189		HIGH:
1.383		ASK:
0.000		VOLUME:
18
CHG(%):
19.95		PREV:
1.153		LOW:
1.189		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
06 Nov 251.1891.3831.1891.38318
05 Nov 251.1531.1531.1531.153178
04 Nov 251.1181.1181.1181.118300
03 Nov 251.1231.1231.1231.123300
31 Oct 251.1211.1211.1211.121300
30 Oct 251.1341.1341.1341.134300
29 Oct 251.1381.1381.1381.138300
28 Oct 251.1401.1401.1401.140300
27 Oct 251.1581.1581.1581.158300
24 Oct 251.1551.1551.1551.155300

COMPANY PROFILE

Name:Pharming Group NV
About:Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. It has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Sector:Healthcare
Industry:Biotechnology
Address:Darwinweg 24, Leiden, Netherlands, 2333 CR
Website:https://www.pharming.com
ISIN:NL0010391025

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:56.95 
Forward P/E:-37.27 
PEG Ratio:-37.27 
Price to Sales:2.28 
Price to Book:3.19 
Profit Margin:-0.02 
Operating Margin:0.03 
Return on Assets:0.03 
Return on Equity:-0.04 
Revenue:294.94M 
EBITDA:12.47M 
Shares:685.15M 
Market Cap:947.56M 

TECHNICAL INDICATORS

MA5:1.1817.2%
MA10:1.1619.0%
MA20:1.1916.7%
MA50:1.2113.8%
MA100:1.0828.6%
MA200:0.9644.6%
STO9:100.00 
STO14:100.00 
RSI14:65.43 
MTM14:0.19
ROC14:0.16 
ATR:0.03 
Week High:1.380.0%
Week Low:1.1223.7%
Month High:1.380.0%
Month Low:1.1244.6%
Year High:1.380.0%
Year Low:0.67105.8%
Volatility:60.41 

RECENT SPLITS

Date Ratio
05 Mar 20131-10